Watch for registration statement filing for resale of the unregistered ADSs and warrants, which could lead to further overhang. Monitor CDMO contract activation and cash collection progress to assess runway extension.
Price Chart
Executive Summary
Scinai closed a $4.0M private placement and warrant inducement, issuing ~2.46M ADSs and warrants for up to ~5.0M additional ADSs. Proceeds will fund CDMO operations and pipeline development, extending cash runway into late 2027 (potentially 2028). The financing is dilutive but provides near-term liquidity for a pre-revenue biotech.
Key Financial Metrics
Key Facts
- Closed private placement of 2,458,334 ADSs (or pre-funded warrants) at undisclosed price, raising ~$4.0M gross.
- Warrant inducement: exercised 879,194 existing warrants at reduced exercise price of $1.20/ADS, issuing additional Series A-1 warrants for up to 1,318,791 ADSs.
- Total potential dilution: up to ~5.0M additional ADSs from Series A-1 warrants (3,687,501 + 1,318,791).
- Cash runway estimated to late 2027; could extend to 2028 if later CDMO phases are activated.
- A.G.P./Alliance Global Partners acted as sole placement agent.
Financial Impact
$4.0M gross proceeds from combined private placement and warrant inducement; dilution from up to ~5.0M additional ADSs if warrants exercised.
Risk Factors
- Significant dilution from warrants (up to ~5.0M ADSs) if exercised.
- Pre-revenue biotech with reliance on CDMO contracts for cash flow; customer termination rights and payment delays are key risks.
- Geopolitical risk from Israel-based operations.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302911221 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 6-K | $0.6813 | awaiting T+60 | — | $0.5310 (−22.06%) |
Oct 16, 2026 11d ago | 6-K | $0.7520 | awaiting T+60 | — | $0.5310 (+29.39%) |
Oct 16, 2026 11d ago | Press Release | $0.7524 | awaiting T+60 | — | $0.5310 (+29.43%) |
Oct 15, 2026 12d ago | 6-K | $0.9015 | awaiting T+60 | — | $0.5310 (+41.10%) |
Oct 13, 2026 14d ago | 6-K | $1.23 | awaiting T+60 | — | $0.5310 (−56.83%) |
Oct 6, 2026 21d ago | EFFECT | $1.22 | awaiting T+60 | — | $0.5310 (+56.48%) |
Sep 21, 2026 5w ago | 6-K | $1.69 | awaiting T+60 | — | $0.5310 (−68.58%) |
Aug 26, 2026 8w ago | 6-K | $2.87 | awaiting T+60 | — | $0.5310 (+81.50%) |
Aug 19, 2026 9w ago | 6-K | $0.2740 | awaiting T+60 | — | $0.5310 (−93.80%) |
Jun 17, 2026 18w ago | 6-K | $0.3370 $0.2440 | ▼ −27.60% | ▼ −30.28% | $0.5310 (+57.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers